CN Patent
CN118403021A — 一种司美格鲁肽片剂
Assigned to Lunan New Time Bio Tech Co ltd · Expires 2024-07-30 · 2y expired
What this patent protects
本发明属于医药制剂技术领域,具体涉及一种司美格鲁肽片剂及其制备方法。本发明司美格鲁肽片剂中将司美格鲁肽用尤特奇E100包衣,并加入生物黏附聚合物,做成双层片,所得片剂能够长时间停留在胃中,有利于司美格鲁肽的吸收,生物利用度高,且稳定性好,易于保存。
USPTO Abstract
本发明属于医药制剂技术领域,具体涉及一种司美格鲁肽片剂及其制备方法。本发明司美格鲁肽片剂中将司美格鲁肽用尤特奇E100包衣,并加入生物黏附聚合物,做成双层片,所得片剂能够长时间停留在胃中,有利于司美格鲁肽的吸收,生物利用度高,且稳定性好,易于保存。
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.